SG
ANGO icon

StoneX Group’s AngioDynamics ANGO Stock Holding History

StoneX Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Sell
43,561
-20,548
-32% -$234K 0.02% 513
2026
Q1 		$729K Buy
64,109
+11,562
+22% +$125K 0.04% 331
2025
Q4 		$675K Sell
52,547
-1,425
-3% -$17.6K 0.03% 445
2025
Q3 		$603K Sell
53,972
-20,419
-27% -$197K 0.03% 483
2025
Q2 		$738K Sell
74,391
-243
-0.3% -$2.38K 0.04% 408
2025
Q1 		$701K Sell
74,634
-32,449
-30% -$341K 0.04% 372
2024
Q4 		$981K Buy
+107,083
New +$787K 0.05% 286

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

StoneX Group's ANGO Position: Q2 2026 in Review

StoneX Group reduced its AngioDynamics (ANGO) stake by 32% in Q2 2026, selling an estimated $234K and leaving 43,561 shares worth $567K. The position accounts for 0.02% of the portfolio, ranked #513.

StoneX Group first reported a position in ANGO in Q4 2024 and has held it in 7 quarters since. The position peaked at $981K in Q4 2024. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • StoneX Group held 43,561 shares of AngioDynamics worth $567K as of Q2 2026.
  • StoneX Group sold 20,548 AngioDynamics shares in Q2 2026, an estimated $234K.
  • AngioDynamics made up 0.02% of StoneX Group's portfolio in Q2 2026, its #513 holding.
  • StoneX Group first reported a position in AngioDynamics in Q4 2024 and has held it in 7 quarters since.
  • StoneX Group's AngioDynamics position peaked at $981K in Q4 2024.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.